Blue Owl Capital Holdings LP
Q3 2026 13F-HR Holdings
Net value change ($000)
-116,890
(-17.6%)
New positions
16
Sold out positions
13
Turnover %
38.1%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q2 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| LATIGO BIOTHERAPEUTICS INC | 60,066 | NEW |
| ELECTRA THERAPEUTICS INC | 29,375 | NEW |
| OBSIDIAN THERAPEUTICS INC | 20,358 | NEW |
| MANE | 5,455 | NEW |
| IRD | 4,693 | NEW |
| RZLT | 3,871 | NEW |
| LRMR | 3,759 | 13.4% |
| ACHV | 3,338 | NEW |
| PCOR | 3,312 | NEW |
| HELP | 3,147 | 794.7% |
Top Reduces (Value $000, Stocks/ETFs)
| SPACE EXPLORATION TECHN CORP | -99,725 | -41.7% |
| AKTS | -33,849 | -34.2% |
| COF | -24,026 | -100.0% |
| MPLT | -20,492 | -78.3% |
| EYPT | -10,905 | -100.0% |
| DEEP FISSION INC | -7,880 | -53.5% |
| RYTM | -6,823 | -100.0% |
| CGEM | -6,551 | -23.4% |
| CMPS | -6,368 | -100.0% |
| RARE | -6,098 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
1,429
(0.3% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|